[ad_1]
Vanda Pharma VNDA reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Vanda Pharma missed estimated earnings by 54.55%, reporting an EPS of $0.05 versus an estimate of $0.11.
Revenue was down $3.51 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.1 which was followed by a 2.04% drop in the share price the next day.
Here’s a look at Vanda Pharma’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.01 | 0.08 | 0.16 | 0.14 |
| EPS Actual | -0.11 | 0.12 | 0.14 | 0.17 |
| Revenue Estimate | 58.00M | 70.04M | 75.00M | 69.75M |
| Revenue Actual | 60.19M | 68.02M | 70.09M | 67.90M |
To track all earnings releases for Vanda Pharma visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.